| 
				
				Re: FDA approves mTor inhibitor afinitor (everolimus) for breast cancer
			 
 It's about time!  It was working on my cancer, but the side effects were completely intolerable. 
				__________________March 2010: Diagnosed with Stage IIIC IDC with axillary, mammary and suplaclavicular node involvement.  ER/PR -, HER2+++.  7cm tumor in right breast.
 April 2010: Started neoadjuvent chemo.  4 DD A/C every 2 weeks, 4 DD Taxotere every 3 weeks with Herceptin weekly.
 August 2010: Finished chemo!
 August 20, 2010: PET/CT showed no cancer in any nodes, and only a little uptake to the breast.
 September 9, 2010: Bilateral mastectomy with immediate reconstruction with implants and Alloderm.
 September 16, 2010: Pathology report showed 18/51 positive axillary nodes, 3.2cm tumor.  Granual sized cancer found in the fatty tissue between levels 1 and 2.
 October 19, 2010: CT showed several spots on lungs and 1 spot on liver.  Liver spot is 2mm, lung spots range from 2mm to 4mm.  We don't know if they are cancer or not.
 12/15/10: Brain MRI clear
 1/7/11: PET/CT
 1/13/11: Recurrence in lungs.  Start Tykerb
 5/13/11: Progression in lungs
 6/3/11: Lung surgery to get tumors for chemosensitivity testing.
 |